Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke

Scott et al conclude that if treatment to modulate plasma glucose is found to be effective, it is likely to be applicable to over two-thirds of acute stroke patients and across the range of clinical stroke subtypes.

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 353; no. 9150; pp. 376 - 377
Main Authors Scott, Jon F, Robinson, Gina M, French, Joyce M, O'Connell, Janice E, Alberti, KGMM, Gray, Christopher S
Format Journal Article
LanguageEnglish
Published London Elsevier Ltd 30.01.1999
Lancet
Elsevier Limited
Subjects
Acute Disease
Age Factors
Biological and medical sciences
Blood Glucose - metabolism
Cerebrovascular Disorders - complications
Cerebrovascular Disorders - epidemiology
Diabetes Complications
Diabetes Mellitus - diagnosis
Humans
Hyperglycemia - complications
Hyperglycemia - diagnosis
Hyperglycemia - epidemiology
Medical research
Medical sciences
Neurology
Patient Admission
Prevalence
Sex Factors
Stroke
Vascular diseases and vascular malformations of the nervous system
Human
Nervous system diseases
Stroke
Prevalence
Acute
Cardiovascular disease
Cerebral disorder
Vascular disease
Hyperglycemia
Association
Clinical management
Central nervous system disease
Classification
Cerebrovascular disease
Online AccessGet full text

Cover

More Information
Summary:Scott et al conclude that if treatment to modulate plasma glucose is found to be effective, it is likely to be applicable to over two-thirds of acute stroke patients and across the range of clinical stroke subtypes.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(05)74948-5